Site Search
Search Results
Idaho Policy Forum: Speaker Bios
... Inc. Dr. Whitney Jones is a Gastroenterologist, a former Clinical Professor of Medicine and current adjunct Professor in the School of Public Health and information services at the University of Louisville. He is a founding member and currently serves as Chair of the Kentucky Colon ... Bio Alliance of Medicine, an organization advocating for the growth of Idaho's biomedical ecosystem, creating a unified voice for biomedical and health research in Idaho. Krishna C. Alluri - MD Oncologist and Hematologist, St. Luke's Cancer Institute Dr. Krishna C. Alluri is board ... York. Before joining Oscar, he led various clinical and business development areas at EmblemHealth, Point-of Care Partners, MedImpact Health Care Systems, and Horizon Blue Cross Blue Shield of New Jersey. Early in his career, he worked at multiple ...
Idaho Cancer Action Day 2024
... In 2018, Idaho voters passed Medicaid expansion with 60% of the vote, sending a strong message that Idahoans wanted to see increased access to health care for their friends and neighbors. Expansion offers coverage to individuals earning up to $20,000 per year, and families of 4 earning up to ... cancer screenings, diagnostic testing, treatment services and follow-up care. Idaho legislators tried to override the will of the voters on health coverage expansion during the 2019 legislative session and it is important that we send a strong message that voters and constituents still ...
New York Biomarker Testing Campaign
... What is biomarker testing? Biomarker testing helps get the right treatment to the right patient at the right time. Progress in improving health outcomes increasingly involves the use of precision medicine, which uses information about a person’s own genes or proteins to prevent, ... of a patient’s tissue, blood, or fluid biospecimen for the presence of a biomarker. Biomarker testing is increasingly important for cancer care – and for the treatment of other diseases. Thirty-seven of the 62 oncology drugs launched in the past five years require or recommend ... biomarker testing when medically appropriate. Improving access to biomarker testing and thereby access to targeted therapies will help reduce health disparities and improve outcomes for cancer patients. Expanding access to biomarker testing will also increase patient diversity in clinical ...
2020 ACS CAN Texas Cancer Policy Forum Series
... Network (ACS CAN) will host its seventh annual Texas Cancer Policy Forum series this fall, uniting key leaders and decision makers in business, health care, and government to consider the evolving needs of Texans accessing and affording equitable cancer care. Texas institutions are generating exciting new life-saving therapies and making advances in the fight against cancer, with significant ...
Expand Access to Biomarker Testing in Nevada
... and partners are working together to make sure more Nevadans can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...
Prescription Drug Affordability in Michigan
ACS CAN supports legislation that restricts the use of so-called copay accumulator adjustments in health insurance plans. We advocate for policies that ensure third party prescription drug copay assistance is counted toward patients’ out-of-pocket cost obligations. Prescription drug affordability safegaurds that patients and their families can care for themselves while reducing the burden of toxic medical debt. Michigan cancer patients and others rely on prescription drug copay ... two cancer survivors struggles without copay accumulators: Video of krin_gary_westby_wisconsin Video of acs_can_barriers_to_care_julie_turner_fc2 Read about the impact of copay accumulators found through our Survivor Views survey: In March & April of 2024, ACS CAN ...
Cancer Votes Issues
... elections, we're focusing on five core issues: Protecting people with pre-existing conditions Increasing funding for cancer research Eliminating health disparities Increasing access to Medicaid Reducing barriers to rural cancer care You can learn more about our work on these issues by visiting the What We Do section of our website. Ready to help us make fighting cancer a ...
2011 How Do You Measure Up Report
... cases, it costs the state little or nothing to do the right thing. In most cases, these solutions will save the state millions of dollars in health care costs and increased worker productivity. Download the report 2011 How Do You Measure Up Report ...
Dr. Mullin: Cornwall, NY
... her job and went into medicine to help people live healthier lives. But too often, Dr. Mullin is prevented from helping her patients achieve health and well-being because of the cost of the drugs her patients need. “Some of these necessary medicines are $300 a month,” she said. ... if we didn’t have to do that.” Ultimately, making medications more accessible and affordable would improve her patients’ overall health, and allow them to manage their chronic conditions effectively. Dr. Mullin hopes that in the future, the cost of a treatment that will improve someone’s quality of life and their health won’t be as unattainable. Read More Stories About Barriers to Care Dr. Mullin: Cornwall, NY ...
Annual Reports and Financials
... sustain investments in cancer research, fund programs that detect cancer at its earliest, most treatable stages, increase access to affordable health care, and reduce health disparities. View the Advocacy Accomplishments report View the 2024 Impact Infographic in English View the 2024 Impact Infographic in ...
Type
- (-) Remove Basic page filter Basic page
Priority Issue
State
- New York (13) Apply New York filter
- California (6) Apply California filter
- Idaho (6) Apply Idaho filter
- New Jersey (6) Apply New Jersey filter
- West Virginia (5) Apply West Virginia filter
- Georgia (4) Apply Georgia filter
- South Dakota (4) Apply South Dakota filter
- Tennessee (4) Apply Tennessee filter
- District Of Columbia (3) Apply District Of Columbia filter
- Florida (3) Apply Florida filter
- Hawaii (3) Apply Hawaii filter
- Kentucky (3) Apply Kentucky filter
- Maine (3) Apply Maine filter
- Maryland (3) Apply Maryland filter
- Massachusetts (3) Apply Massachusetts filter
- Michigan (3) Apply Michigan filter
- Missouri (3) Apply Missouri filter
- Texas (3) Apply Texas filter
- Alabama (2) Apply Alabama filter
- Connecticut (2) Apply Connecticut filter
- Louisiana (2) Apply Louisiana filter
- Minnesota (2) Apply Minnesota filter
- Montana (2) Apply Montana filter
- National (2) Apply National filter
- Nevada (2) Apply Nevada filter
- New Hampshire (2) Apply New Hampshire filter
- North Carolina (2) Apply North Carolina filter
- Oklahoma (2) Apply Oklahoma filter
- Rhode Island (2) Apply Rhode Island filter
- Vermont (2) Apply Vermont filter
- Wyoming (2) Apply Wyoming filter
- Arizona (1) Apply Arizona filter
- Arkansas (1) Apply Arkansas filter
- Colorado (1) Apply Colorado filter
- Delaware (1) Apply Delaware filter
- Iowa (1) Apply Iowa filter
- Ohio (1) Apply Ohio filter
- Pennsylvania (1) Apply Pennsylvania filter
- South Carolina (1) Apply South Carolina filter
- Virginia (1) Apply Virginia filter
- Washington (1) Apply Washington filter
- Wisconsin (1) Apply Wisconsin filter